Ipsen Biopharmaceuticals, Inc. v. Xavier Becerra

108 F.4th 836
CourtCourt of Appeals for the D.C. Circuit
DecidedJuly 9, 2024
Docket23-5142
StatusPublished
Cited by4 cases

This text of 108 F.4th 836 (Ipsen Biopharmaceuticals, Inc. v. Xavier Becerra) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ipsen Biopharmaceuticals, Inc. v. Xavier Becerra, 108 F.4th 836 (D.C. Cir. 2024).

Opinion

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT ____________ No. 23-5142 September Term, 2023 1:22-cv-00860-DLF Filed On: July 9, 2024 Ipsen Biopharmaceuticals, Inc.,

Appellant

v.

Xavier Becerra, in his official capacity as Secretary of Health and Human Services, et al.,

Appellees

BEFORE: Wilkins, Katsas and Rao, Circuit Judges

UNDER SEAL OPINION NOT AVAILABLE TO PUBLIC

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
108 F.4th 836, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ipsen-biopharmaceuticals-inc-v-xavier-becerra-cadc-2024.